Literature DB >> 22893465

Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure.

Rishikesh M Kulkarni1, Louis W Kutcher, William D Stuart, Daniel J Carson, Mike A Leonis, Susan E Waltz.   

Abstract

BACKGROUND: Prior experimentation has shown that loss of the tyrosine kinase (TK) signaling domain of the Ron receptor leads to marked hepatocyte protection in a model of lipopolysaccharide-induced acute liver failure (ALF) in D-galactosamine (GalN)-sensitized mice. The aim of this study was to identify the role of Ron in the regulation of hepatic gene expression.
METHODS: Microarray analyses were performed on liver RNA isolated sequentially from wild-type (WT) and TK-/- mice during the progression of ALF. Gene array data were validated using Western and immunohistochemistry analyses as well as with ex vivo culture systems.
RESULTS: At baseline, 101 genes were differentially expressed between WT and TK-/- livers, which regulate processes involved in hypoxia, proliferation, apoptosis and metabolism. One hour after ALF induction, WT livers exhibited increased cytokine expression compared to TK-/- livers, and after 4 hours, an induction of suppressor of cytokine signaling (SOCS) genes as well as JAK-STAT pathway activation were prominent in TK-/- livers compared to controls.
CONCLUSION: Our studies suggest a novel hepato-protective mechanism in Ron TK-/- mice wherein increased and sustained SOCS production and JAK-STAT activation in the hepatocyte may inhibit the destructive proinflammatory milieu and promote survival factors which blunt hepatic death and the ensuing development of ALF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893465      PMCID: PMC4102423          DOI: 10.1016/s1499-3872(12)60196-9

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  45 in total

1.  SOCS-1 participates in negative regulation of LPS responses.

Authors:  Reiko Nakagawa; Tetsuji Naka; Hiroko Tsutsui; Minoru Fujimoto; Akihiro Kimura; Tatsuo Abe; Ekihiro Seki; Shintaro Sato; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira; Koichi Yamanishi; Ichirou Kawase; Kenji Nakanishi; Tadamitsu Kishimoto
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

Review 2.  The JAK/STAT signaling pathway.

Authors:  Jason S Rawlings; Kristin M Rosler; Douglas A Harrison
Journal:  J Cell Sci       Date:  2004-03-15       Impact factor: 5.285

Review 3.  Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death.

Authors:  K Decker; D Keppler
Journal:  Rev Physiol Biochem Pharmacol       Date:  1974       Impact factor: 5.545

4.  The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.

Authors:  Y Konishi; H Shinozuka; J L Farber
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

5.  Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice.

Authors:  I Hishinuma; J Nagakawa; K Hirota; K Miyamoto; K Tsukidate; T Yamanaka; K Katayama; I Yamatsu
Journal:  Hepatology       Date:  1990-11       Impact factor: 17.425

6.  SOCS1/JAB is a negative regulator of LPS-induced macrophage activation.

Authors:  Ichiko Kinjyo; Toshikatsu Hanada; Kyoko Inagaki-Ohara; Hiroyuki Mori; Daisuke Aki; Masanobu Ohishi; Hiroki Yoshida; Masato Kubo; Akihiko Yoshimura
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

7.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia.

Authors:  Anton A Igonin; Victor W Armstrong; Maria Shipkova; Natalya B Lazareva; Vladimir G Kukes; Michael Oellerich
Journal:  Clin Biochem       Date:  2004-03       Impact factor: 3.281

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP.

Authors:  G Gaudino; A Follenzi; L Naldini; C Collesi; M Santoro; K A Gallo; P J Godowski; P M Comoglio
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

View more
  2 in total

1.  LPS pretreatment ameliorates D-galactosamine/lipopolysaccharide-induced acute liver failure in rat.

Authors:  Jin-Zhong Dong; Li-Ping Wang; Sai-Nan Zhang; Ke-Qing Shi; Shao-Long Chen; Nai-Bin Yang; Shun-Lan Ni; Jian-Hua Zhu; Ming-Qin Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Ron receptor-dependent gene regulation of Kupffer cells during endotoxemia.

Authors:  Rishikesh M Kulkarni; William D Stuart; Susan E Waltz
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2014-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.